Psychopharmacology and Cardiovascular Disease
Open accessAbstract
This review discusses common mental health disorders and their associations with cardiovascular disease risks. Commonly found mental health disorders include depression, anxiety, and personality types. The link between depression and cardiovascular disease mortality has been established. Depression is also common in patients with heart failure. In addition to discussing psychological disorders, a review of psychotropic drugs is also included. Drugs are described for therapy for depression and anxiety, as well as associations with cardiovascular drug-drug interactions. Drug-drug interactions are more common and potentially dangerous in elderly patients, in whom the conditions often coexist. The most common drug-drug interactions involve the P450 system of enzymes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pharmacotherapy treatment for mental health disorders can present cardiovascular risk due to side effects of the drugs or interactions with other medications.
“Pharmacotherapy treatment for mental health disorders can present cardiovascular risk due to side effects of the drugs or interactions with other medications (Pina 2018).”
From Psychotherapeutic treatments for depression in older adults (2024) · cites this paper as Pina 2018
Pharmacological treatment of depression in patients with CVD has small effects and may be burdensome and increase the risk of side effects.
“Pharmacological treatment of depression may be an option in patients with CVD, but the effects are small [1]. Moreover, such treatment poses a challenge as adding another medication to the existing complex medical treatment may be perceived as burdensome and might increase the risk of developing side effects [3].”
From An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208 · see citing works
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976 · see citing works
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846 · see citing works
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705 · see citing works
Rosengren, A., Hawken, S., Ôunpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W. A., Blackett, K. N., Sitthi-amorn, C., Sato, H., & Yusuf, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17019-0 · Cited by 2,414 · see citing works
Depression Following Myocardial Infarction
Frasure‐Smith, N. (1993) · JAMA · doi:10.1001/jama.1993.03510150053029 · Cited by 2,028 · see citing works
Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men.
Karasek, R. A., Baker, D. B., Marxer, F., Ahlbom, A., & Theorell, T. (1981) · American Journal of Public Health · doi:10.2105/ajph.71.7.694 · Cited by 1,566 · see citing works
Depression and 18-Month Prognosis After Myocardial Infarction
Frasure‐Smith, N., Lespérance, F., & Talajic, M. R. (1995) · Circulation · doi:10.1161/01.cir.91.4.999 · Cited by 1,546 · see citing works
Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.055 · Cited by 1,513 · see citing works
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · see citing works
Lichtman, J. H., Bigger, J. T., Blumenthal, J. A., Frasure-Smith, N., Kaufmann, P. G., Lespérance, F., Mark, D. B., Sheps, D. S., Taylor, C. B., & Froelicher, E. S. (2008) · Circulation · doi:10.1161/circulationaha.108.190769 · Cited by 1,482 · see citing works
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358 · see citing works
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353 · see citing works
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137 · see citing works
Depression as a predictor for coronary heart disease
Rugulies, R. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00439-7 · Cited by 1,110 · see citing works
(2007) · PubMed · Cited by 953 · see citing works
Depression and the risk for cardiovascular diseases: Systematic review and meta analysis
Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., & Beekman, A. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1723 · Cited by 951 · see citing works
Anxiety and Risk of Incident Coronary Heart Disease
Roest, A. M., Martens, E. J., de Jonge, P., & Denollet, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.034 · Cited by 865 · see citing works
Sudden Cardiac Death Triggered by an Earthquake
Leor, J., Poole, W. K., & Kloner, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340701 · Cited by 819 · see citing works
The Association of Anger and Hostility With Future Coronary Heart Disease
Chida, Y., & Steptoe, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.044 · Cited by 774 · see citing works
Lespérance, F., Frasure‐Smith, N., Talajic, M. R., & Bourassa, M. G. (2002) · Circulation · doi:10.1161/hc0902.104707 · Cited by 722 · see citing works
Chida, Y., & Hamer, M. (2008) · Psychological Bulletin · doi:10.1037/a0013342 · Cited by 667 · see citing works
Depression as a risk factor for mortality after coronary artery bypass surgery
Blumenthal, J. A., Lett, H. S., Babyak, M. A., White, W., Smith, P. K., Mark, D. B., Jones, R., Mathew, J. P., & Newman, M. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14190-6 · Cited by 662 · see citing works
Guidelines for the Rational Use of Benzodiazepines: When and What to Use
Ashton, H. (1994) · Drugs · doi:10.2165/00003495-199448010-00004 · Cited by 593 · see citing works
Type A Behavior, Hostility, and Coronary Atherosclerosis*
Williams, R. B., Haney, T. L., Lee, K. L., Kong, Y., Blumenthal, J. A., & Whalen, R. E. (1980) · Psychosomatic Medicine · doi:10.1097/00006842-198011000-00002 · Cited by 592 · see citing works
Exaggerated platelet reactivity in major depression
Musselman, D. L., Tomer, A., Manatunga, A. K., Knight, B. T., Porter, M. R., Kasey, S., Marzec, U. M., Harker, L. A., & Nemeroff, C. B. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.10.1313 · Cited by 566 · see citing works
β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Ko, D. T. (2002) · JAMA · doi:10.1001/jama.288.3.351 · Cited by 557 · see citing works
Tindle, H. A., Chang, Y.-F., Kuller, L. H., Manson, J. E., Robinson, J. G., Rosal, M. C., Siegle, G. J., & Matthews, K. A. (2009) · Circulation · doi:10.1161/circulationaha.108.827642 · Cited by 483 · see citing works
Association of depression witk reduced heart rate variability in coronary artery disease
Carney, R. M., Saunders, R. D., Freedland, K. E., Stein, P. K., Rich, M. W., & Jaffe, A. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80155-6 · Cited by 482 · see citing works
Krantz, D. S., & McCeney, M. K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135208 · Cited by 469 · see citing works
The influence of age, gender, and race on the prevalence of depression in heart failure patients
Gottlieb, S. S., Khatta, M., Friedmann, E., Einbinder, L., Katzen, S. M., Baker, B., Marshall, J. P., Minshall, S., Robinson, S., Fisher, M. L., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.064 · Cited by 468 · see citing works
Prescribing Trends in Psychotropic Medications
Pincus, H. A., Tanielian, T., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & ZITO, J. M. (1998) · JAMA · doi:10.1001/jama.279.7.526 · Cited by 423 · see citing works
Adverse drug events as a cause of hospital admission in the elderly
Chan, M., Nicklason, F., & Vial, J. H. (2001) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2001.00044.x · Cited by 412 · see citing works
Inadequate Response to Treatment in Coronary Heart Disease
Denollet, J., Vaes, J., & Brutsaert, D. L. (2000) · Circulation · doi:10.1161/01.cir.102.6.630 · Cited by 388 · see citing works
Drug Interactions Due to Cytochrome P450
Ogu, C. C., & Maxa, J. L. (2000) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2000.11927719 · Cited by 370 · cited 1× · see citing works
“There are at least 40 such enzymes, but 6 of them appear to be responsible for >90% of drug metabolism (122,123): CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4.”
BackgroundEmotional and physical precipitants of ventricular arrhythmia
Lampert, R., Joska, T., Burg, M. M., Batsford, W. P., McPherson, C. A., & Jain, D. (2002) · Circulation · doi:10.1161/01.cir.0000031733.51374.c1 · Cited by 347 · see citing works
Effects of Mental Stress on Myocardial Ischemia During Daily Life
Gullette, E. C. D. (1997) · JAMA · doi:10.1001/jama.1997.03540430033029 · Cited by 346 · see citing works
Relationship of Depression to Death or Hospitalization in Patients With Heart Failure
Sherwood, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.367 · Cited by 342 · see citing works
Phobic Anxiety and Risk of Coronary Heart Disease and Sudden Cardiac Death Among Women
Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., & Kawachi, I. I. (2005) · Circulation · doi:10.1161/01.cir.0000153813.64165.5d · Cited by 330 · see citing works
Work-Related Psychosocial Factors and the Development of Ischemic Heart Disease: A Systematic Review
Eller, N. H., Netterstrøm, B., Gyntelberg, F., Kristensen, T. S., Nielsen, F., Steptoe, A., & Theorell, T. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e318198c8e9 · Cited by 323 · see citing works
Mental stress--induced myocardial ischemia and cardiac events
Jiang, W. (1996) · JAMA · doi:10.1001/jama.275.21.1651 · Cited by 318 · see citing works
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317 · see citing works
Blumenthal, J. A., Babyak, M. A., O’Connor, C., Keteyian, S., Landzberg, J., Howlett, J., Kraus, W., Gottlieb, S., Blackburn, G., Swank, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.8720 · Cited by 305 · see citing works
Denollet, J., Schiffer, A. A., & Spek, V. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.934406 · Cited by 282 · see citing works
Depression and vascular disease: what is the relationship?
Thomas, A. J. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00349-x · Cited by 267 · see citing works
Anxiety, Depression, and Cause-Specific Mortality: The HUNT Study
Mykletun, A., Bjerkeset, O. A., Dewey, M. E., Prince, M. J., Øverland, S. N., & Stewart, R. J. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31803cb862 · Cited by 265 · see citing works
Early-Onset Depression, Anxiety, and Risk of Subsequent Coronary Heart Disease
Janszky, I., Ahnve, S., Lundberg, I., & Hemmingsson, T. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.033 · Cited by 260 · see citing works
Strik, J. J. M. H., Honig, A., Lousberg, R. L., Lousberg, A., Cheriex, E. C., Tuynman-Qua, H. G., Kuijpers, P. M. J. C., Wellens, H. J. J., & van Praag, H. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00007 · Cited by 255 · see citing works
Meta-Analysis of Selective Serotonin Reuptake Inhibitor–Associated QTc Prolongation
Beach, S. R., Kostis, W. J., Celano, C. M., Januzzi, J. L., Ruskin, J. N., Noseworthy, P. A., & Huffman, J. C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08672 · Cited by 253 · see citing works
Kamarck, T. W., Everson‐Rose, S. A., Kaplan, G. A., Manuck, S. B., Jennings, J. R., Salonen, R. M., & Salonen, J. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.3842 · Cited by 248 · see citing works
Mental Stress—Induced Myocardial Ischemia and Cardiac Events
Jiang, W. (1996) · JAMA · doi:10.1001/jama.1996.03530450041030 · Cited by 248 · see citing works
Tonstad, S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00003-4 · Cited by 246 · see citing works
Pharmacologic treatment of anxiety disorders.
MAVISSAKALIAN, M. R. (1982) · PubMed · Cited by 243 · see citing works
Buspirone: What is it all about?
Loane, C., & Politis, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.032 · Cited by 223 · see citing works
Increased antidepressant use in patients prescribed beta-blockers
Avorn, J. (1986) · JAMA · doi:10.1001/jama.255.3.357 · Cited by 218 · see citing works
Steinberg, J. S., Arshad, A., Kowalski, M., Kukar, A., Suma, V. S., Vloka, M. E., EHLERT, F. A., Herweg, B., Donnelly, J., Philip, J., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.032 · Cited by 205 · see citing works
Propranolol-induced depression.
Waal, H. J. (1967) · BMJ · doi:10.1136/bmj.2.5543.50 · Cited by 205 · see citing works
Pizzi, C., Rutjes, A. W. S., Costa, G. M., Fontana, F., Mezzetti, A., & Manzoli, L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.017 · Cited by 203 · see citing works
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly
Atkin, P. A., Veitch, P. C., Veitch, E. M., & OGLE, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203 · see citing works
Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility
Myrtek, M. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00441-7 · Cited by 190 · see citing works
Depression in Patients Recovering From a Myocardial Infarction
Ziegelstein, R. C. (2001) · JAMA · doi:10.1001/jama.286.13.1621 · Cited by 187 · see citing works
Cardiac side effects of psychiatric drugs
Mackin, P. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.915 · Cited by 176 · see citing works
Gabbay, F. H., Krantz, D. S., Kop, W. J., Hedges, S. M., Klein, J., Gottdiener, J. S., & Rozanski, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00510-2 · Cited by 175 · see citing works
Cardiovascular effects of bupropion in depressed patients with heart disease
Roose, S. P., Dalack, G. W., Glassman, A. H., Woodring, S., Walsh, B. T., & Giardina, E. V. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.512 · Cited by 167 · see citing works
Phillips, A. C., Batty, G. D., Galé, C. R., Deary, I. J., Osborn, D., Macintyre, K., & Carroll, D. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31819e6706 · Cited by 167 · see citing works
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney, R. M., & Freedland, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081239 · Cited by 163 · cited 6× · see citing works
“However, because selective serotonin reuptake inhibitors (SSRIs) are commonly used as antidepressants in patients with CAD, who are also likely to receive antiplatelet agents, the potential interaction of a serotonin transporter inhibitor with aspirin (ASA) and/or clopidogrel is worth noting (31–33).”
BackgroundInfluentialKrantz, D. S., Kop, W. J., Santiago, H. T., & Gottdiener, J. S. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70280-0 · Cited by 159 · see citing works
Labos, C., Dasgupta, K., Nedjar, H., Turecki, G., & Rahme, E. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.100912 · Cited by 159 · see citing works
Mental Health and Cardiovascular Disease
Chaddha, A., Robinson, E. A., Kline-Rogers, E. M., Alexandris-Souphis, T., & Rubenfire, M. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.05.018 · Cited by 148 · see citing works
Increased Antidepressant Use in Patients Prescribed β-Blockers
Avorn, J. (1986) · JAMA · doi:10.1001/jama.1986.03370030077031 · Cited by 147 · see citing works
Pizzi, C., Mancini, S., Angeloni, L., Fontana, F., Manzoli, L., & Costa, G. M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.121 · Cited by 146 · see citing works
Rutledge, T., Linke, S., Krantz, D. S., Johnson, B. D., Bittner, V., Eastwood, J., Eteiba, W., Pepine, C. J., Vaccarino, V., Francis, J., et al. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181bd6062 · Cited by 134 · see citing works
Gottlieb, S. S., Kop, W. J., Ellis, S. J., Binkley, P., Howlett, J., O'Connor, C., Blumenthal, J. A., Fletcher, G., Swank, A. M., & Cooper, L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.025 · Cited by 133 · see citing works
Increased prescribing of antidepressants subsequent to beta-blocker therapy
Thiessen, B. Q. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.11.2286 · Cited by 131 · see citing works
Schneier, F. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060145 · Cited by 119 · see citing works
INCREASE IN DEATHS FROM ISCHÆMIC HEART-DISEASE AFTER BLIZZARDS
Glass, R. I., & Zack, M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90835-3 · Cited by 114 · see citing works
Role of Exertion or Emotion as Inciting Events for Acute Aortic Dissection
Hatzaras, I. S., Bible, J. E., Koullias, G. J., Tranquilli, M., Singh, M., & Elefteriades, J. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.039 · Cited by 110 · see citing works
Correlation between the dexamethasone suppression test in depressed patients and clinical response
Nemeroff, C. B., & Evans, D. L. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.2.247 · Cited by 110 · see citing works
Understanding the pharmacokinetics of anxiolytic drugs
Altamura, A. C., Moliterno, D., Paletta, S., Maffini, M., Mauri, M. C., & Bareggi, S. R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759209 · Cited by 110 · see citing works
Depressive Symptoms and Outcomes in Patients with Heart Failure: Data from the COACH Study
Lesman‐Leegte, I., van Veldhuisen, D. J., Hillege, H. L., Moser, D. K., Sanderman, R., & Jaarsma, T. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp155 · Cited by 108 · see citing works
Beta-blockers and depression. Evidence against an association
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.267.13.1783 · Cited by 103 · see citing works
Depression and Congestive Heart Failure
Guck, T. P., Elsasser, G. N., Kavan, M., & J., E. J. E. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2003.01356.x · Cited by 102 · see citing works
Meier, C. R., Schlienger, R. G., & Jick, H. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01426.x · Cited by 101 · see citing works
Jiang, W., O’Connor, C. M., Silva, S. G., Kuchibhatla, M. N., Cuffe, M. S., Callwood, D. D., Zakhary, B., Henke, E., Arias, R. M., & Krishnan, R. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.003 · Cited by 101 · see citing works
Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
English, B. A., Dortch, M. J., Ereshefsky, L., & Jhee, S. S. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0284-9 · Cited by 101 · see citing works
Denollet, J., Maas, K., Knottnerus, J. A., Keyzer, J. J., & Pop, V. J. M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.08.006 · Cited by 98 · see citing works
Increased Prescribing of Antidepressants Subsequent to ß-Blocker Therapy
Thiessen, B. Q. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390220044009 · Cited by 95 · see citing works
Pharmacological treatment of generalized anxiety disorder
Reinhold, J. A., Mandos, L. A., Rickels, K., & Lohoff, F. W. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.618496 · Cited by 90 · see citing works
Roose, S. P., Glassman, A. H., Giardina, E. V., Johnson, L. L., Walsh, B. T., & Bigger, J. T. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198708000-00007 · Cited by 85 · see citing works
Javors, M. A., Houston, J. P., Tekell, J. L., Brannan, S. K., & Frazer, A. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570000198x · Cited by 77 · see citing works
Wulsin, L. R. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490447191 · Cited by 74 · see citing works
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.1992.03480130099032 · Cited by 72 · see citing works
Abnormal Platelet Aggregation Associated with Fluoxetine Therapy
Alderman, C., Moritz, C. K., & Ben-Tovim, D. I. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202601205 · Cited by 68 · see citing works
Acute psychosocial stress and cardiovascular events
Stalnikowicz, R., & Tsafrir, A. (2002) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2002.34788 · Cited by 62 · see citing works
Carney, R. M., Rich, M. W., tevelde, A., Saini, J., Clark, K. A., & Freedland, K. E. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90689-9 · Cited by 54 · see citing works
Smith, P. J., & Blumenthal, J. A. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.06.003 · Cited by 52 · see citing works
Versteeg, H., Theuns, D. A. M. J., Erdman, R. A. M., Jordaens, L. J. L. M., & Pedersen, S. S. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.108 · Cited by 52 · see citing works
Phobic Anxiety and Increased Risk of Mortality in Coronary Heart Disease
Watkins, L. L., Blumenthal, J. A., Babyak, M. A., Davidson, J. R. T., McCants, C. B., O’Connor, C. J., & Sketch, M. H. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181e9f357 · Cited by 51 · see citing works
Digitalis and β-blocking agents: Effects on depression following myocardial infarction
Schleifer, S. J., Slater, W., Macari-Hinson, M. M., Coyle, D. A., Kahn, M., Zucker, H. D., & Gorlin, R. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90144-7 · Cited by 50 · see citing works
Cardiologic side effects of psychotropic drugs
Marano, G., Gianandrea, T., Romagnoli, E., Valeria, C., Lotrionte, M., Antonio, A., Biondi‐Zoccai, G., & Mazza, M. (2012) · 老年心脏病学杂志:英文版 · doi:10.3724/sp.j.1263.2011.00243 · Cited by 46 · see citing works
Is the Use of Psychotropic Drugs Associated with Increased Risk of Ischemic Heart Disease?
Lapane, K. L., Zierkr, S., Lasater, T. M., Barbour, M. M., Carleton, R. A., & Hume, A. L. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00008 · Cited by 45 · see citing works
Tousoulis, D., Drolias, A., Antoniades, C. A., Vasiliadou, C., Marinou, K., Latsios, G., Stefanadi, E., Gounari, P., Siasos, G., Παπαγεωργίου, Ν., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.02.013 · Cited by 44 · see citing works
Giardina, E. V., Johnson, L. L., Vita, J. A., Bigger, J. T., & Brem, R. F. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90240-6 · Cited by 44 · see citing works
Smith, P. J., & Blumenthal, J. A. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.06.003 · Cited by 39 · see citing works
Mazur, A., Strasberg, B., Kusniec, J., & Sclarovsky, S. (1995) · International Journal of Cardiology · doi:10.1016/0167-5273(95)02435-y · Cited by 35 · see citing works
Role of depression in heart failure — Choosing the right antidepressive treatment
Tousoulis, D., Antonopoulos, A. S., Antoniades, C. A., Saldari, C., Stefanadi, E., Siasos, G., Stougianos, P., Plastiras, A., Korompelis, P., & Stefanadis, C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.022 · Cited by 33 · see citing works
Rajeswaran, T., Plymen, C. M., & Doherty, A. M. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1401085 · Cited by 32 · see citing works
Trazodone-Related Exercise-Induced Nonsustained Ventricular Tachycardia
Vitullo, R. N., Wharton, J. M., Allen, N. B., & Pritchett, E. L. C. (1990) · CHEST Journal · doi:10.1378/chest.98.1.247 · Cited by 30 · see citing works
Associations of Job Strain and Occupation with Subclinical Atherosclerosis: The CARDIA Study
Greenlund, K. J., Kiefe, C. I., Giles, W. H., & Liu, K. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2010.02.007 · Cited by 28 · see citing works
Kim, Y.-H., Kim, H.-B., Kim, D.-H., Kim, J., & Shin, H. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.282 · Cited by 28 · see citing works
Liu, X., Lou, X., Cheng, X., & Meng, Y. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s124497 · Cited by 26 · see citing works
Adverse Cardiac Events in Older Patients Receiving Venlafaxine
Ho, J. M.-W., Gomes, T., Straus, S. E., Austin, P. C., Mamdani, M., & Juurlink, D. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08508 · Cited by 25 · see citing works
Cremona-Barbaro, A. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92786-1 · Cited by 24 · see citing works
Effects of psychopharmacological treatment with antidepressants on the vascular system
Kahl, K. G., Westhoff‐Bleck, M., & Krüger, T. H. C. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.07.004 · Cited by 23 · see citing works
Cardiovascular Effects of Psychotropic Drugs
Kovacs, D., & Arora, R. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31802e4b9f · Cited by 23 · see citing works
Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro *
Donnell, C. G. M., Shorten, G. D., & Pelt, F. N. A. M. V. (2005) · Anaesthesia · doi:10.1111/j.1365-2044.2005.04110.x · Cited by 23 · see citing works
Scott, M. J. (2009) · Routledge eBooks · doi:10.4324/9780203879719-12 · Cited by 17 · see citing works
Heart and mind: (2) psychotropic and cardiovascular therapeutics
Shah, S. U., Iqbal, Z., White, A., & White, S. L. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.015230 · Cited by 17 · see citing works
Khan, S., Melikian, N., Shabeeh, H., Cabaco, A. R., Martin, K., Khan, F., O’Gallagher, K., Chowienczyk, P., & Shah, A. M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00745.2016 · Cited by 15 · see citing works
Hoogwegt, M. T., Kupper, N. H. M., Theuns, D. A. M. J., Jordaens, L. J. L. M., & Pedersen, S. S. (2011) · EP Europace · doi:10.1093/europace/eur295 · Cited by 13 · see citing works
Boschmans, S.-A., Perkin, M. F., Terblanche, S. E., & Opie, L. H. (1989) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(89)90022-0 · Cited by 12 · see citing works
Unrug, A., Bener, J., Barry, R. J., van Luijtelaar, E. L. J. M., Coenen, A. M. L., & Kaiser, J. (1997) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(96)00744-1 · Cited by 11 · see citing works
Scott, M. J. (2012) · doi:10.4324/9780203808191-12 · Cited by 8 · see citing works
Effects of triazolam on heart rate level and on phasic cardiac response to noise during sleep
Libert, J., Amoros, C., Muzet, A. G., Ehrhart, J., & Nisi, J. D. (1988) · Psychopharmacology · doi:10.1007/bf00177559 · Cited by 7 · see citing works
Orth-Gomér, K., Wamala, S. P., Horsten, M., Schenck-Gustafsson, K., Schneiderman, N., & Mittleman, M. A. (2000) · JAMA · doi:10.1001/jama.284.23.3008 · Cited by 6 · see citing works
[PsyCoLaus: mental disorders and cardiovascular diseases: spurious association?].
Preisig, M., Waeber, G., Mooser, V., & Vollenweider, P. (2011) · PubMed · Cited by 5 · see citing works
Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients
Ozturk, Z., & Turkyilmaz, A. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1360829 · Cited by 5 · see citing works
Flagged first, then by citations
2 of the 131 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Krantz DS, Kop WJ, Santiago HT, Gottdiener JS. Mental stress as a trigger of myocardial ischemia and infarction. Cardiology clinics 1996;14(2):271-87.
- Ashton H. Guidelines for the rational use of benzodiazepines. Drugs 1994;48:25-40.
Cited by
Sorted by citations
Screening and Management of Depression in Patients With Cardiovascular Disease
Jha, M. K., Qamar, A., Vaduganathan, M., Charney, D. S., & Murrough, J. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.041 · Cited by 376 · see citing works
Severe Mental Illness and Cardiovascular Disease
Goldfarb, M., Binder, M. D., Detraux, J., Palo, K. E. D., Munir, H., Music, S., Piña, I. L., & Ringen, P. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.017 · Cited by 250 · see citing works
Self-citationDepression and Heart Failure: The Lonely Comorbidity
Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1865 · Cited by 240 · see citing works
Bueno, H., Deaton, C., Farrero, M., Forsyth, F., Braunschweig, F., Buccheri, S., Dragan, S. R., Gevaert, S., Held, C., Kurpas, D., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf191 · Cited by 209 · see citing works
Zambrano, J., Celano, C. M., Januzzi, J. L., Massey, C. N., Chung, W., Millstein, R. A., & Huffman, J. C. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018686 · Cited by 108 · see citing works
Depression, Anxiety, and Cognitive Impairment
Angermann, C. E., & Ertl, G. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0414-8 · Cited by 103 · see citing works
Johansson, P., Westas, M., Andersson, G., Alehagen, U., Broström, A., Jaarsma, T., Mourad, G., & Lundgren, J. (2019) · JMIR Mental Health · doi:10.2196/14648 · Cited by 77 · see citing works
Frontiers and Hotspots Evolution in Psycho-cardiology: A Bibliometric Analysis From 2004 to 2022
Ge, Y., Chao, T., Sun, J., Liu, W., Chen, Y., & Wang, C. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101361 · Cited by 72 · see citing works
Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
Sepúlveda-Lizcano, L., Arenas-Villamizar, V. V., Jaimes-Duarte, E. B., García-Pacheco, H., Paredes, C. S., Bermúdez, V., & Rivera-Porras, D. (2023) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe13080110 · Cited by 77 · see citing works
Depression and coronary heart disease: mechanisms, interventions, and treatments
Xu, L., Zhai, X., Shi, D.-Z., & Zhang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1328048 · Cited by 72 · see citing works
Ski, C. F., Taylor, R. S., McGuigan, K., Long, L., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508.pub3 · Cited by 79 · see citing works
Pellikaan, K., Rosenberg, A. G. W., Kattentidt‐Mouravieva, A. A., Kersseboom, R., Bos‐Roubos, A. G., Veen-Roelofs, J. M. C., Wieringen, N. V. A.-V., Hoekstra, F. M. E., van den Berg, S. A. A., van der Lely, A. J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa621 · Cited by 56 · see citing works
Schnabel, R. B., Hasenfuß, G., Buchmann, S. J., Kahl, K. G., Aeschbacher, S., Osswald, S., & Angermann, C. E. (2021) · Herz · doi:10.1007/s00059-021-05022-5 · Cited by 46 · see citing works
Depression and ischemic heart disease
Pivato, C. A., Chandiramani, R., Petrović, M., Nicolas, J., Spirito, A., Cao, D., & Mehran, R. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.05.056 · Cited by 42 · see citing works
Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis
Park, K., Kim, S., Ko, Y.-J., & Park, B. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.022 · Cited by 42 · see citing works
Atrial Fibrillation and Stress
Segan, L., Prabhu, S., Kalman, J. M., & Kistler, P. M. (2022) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2021.12.008 · Cited by 39 · see citing works
The Impact of Cognitive Impairment on Cardiovascular Disease
Jamil, Y., Krishnaswami, A., Orkaby, A. R., Stimmel, M. B., Brown, C. H., Mecca, A. P., Forman, D. E., Rich, M. W., Nanna, M. G., & Damluji, A. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.057 · Cited by 39 · see citing works
Chobufo, M. D., Khan, S. A., Agbor, V. N., Rahman, E. U., Foryoung, J. B., Jolayemi, A., Jonnadula, S., Patel, N., Enoru, S. T., Dufresne, A., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.09.028 · Cited by 35 · see citing works
Cao, Z., Hou, Y., Yang, H., Huang, X., Wang, X., & Xu, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.048 · Cited by 31 · see citing works
Spontaneous Coronary Artery Dissection
Crousillat, D. R., Sarma, A. A., Wood, M. J., Naderi, S., Leon, K. K., Gibson, C. M., Aday, A. W., Grodzinsky, A., Izard, K., Kovacic, J. C., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101385 · Cited by 26 · see citing works
Mental disorders and cardiovascular disease: what should we be looking out for?
Michal, M., & Beutel, M. E. (2021) · Heart · doi:10.1136/heartjnl-2019-316379 · Cited by 25 · see citing works
Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years
Mesrine, S., Gusto, G., Clavel‐Chapelon, F., Boutron‐Ruault, M., & Fournier, A. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2515-4 · Cited by 24 · see citing works
Out-of-hospital cardiac arrest in patients with psychiatric disorders — Characteristics and outcomes
Barcella, C. A., Mohr, G. H., Kragholm, K. H., Blanche, P., Gerds, T. A., Wissenberg, M., Hansen, S. M., Ringgren, K. B., Lippert, F. K., Folke, F., et al. (2019) · Resuscitation · doi:10.1016/j.resuscitation.2019.07.008 · Cited by 24 · see citing works
Bedeutung von psychosozialen Faktoren in der Kardiologie – Update 2024
Kindermann, I., Köllner, V., Albus, C., Boer, J., Dannberg, G., Fritzsche, K., Gunold, H., Herrmann‐Lingen, C., Leithäuser, B., Meesmann, M., et al. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00708-6 · Cited by 26 · see citing works
Hargrave, A. S., Sumner, J. A., Ebrahimi, R., & Cohen, B. E. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01809-y · Cited by 22 · see citing works
Neuropsychiatric disorders in patients with heart failure: not to be ignored
Manolis, T. A., Manolis, A. S., Melita, H., & Manolis, A. S. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10290-2 · Cited by 20 · see citing works
Network analysis of anxiety and depressive symptoms among patients with heart failure
Zhao, Q., Sun, X., Zhang, Y., Zhang, Y., & Chen, C. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06259-0 · Cited by 21 · see citing works
Palo, K. E. D., Feder, S. L., Baggenstos, Y. T., Cornelio, C. K., Forman, D. E., Goyal, P., Kwak, M. J., & McIlvennan, C. K. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000131 · Cited by 20 · see citing works
Psychological Disorders in Heart Failure
Palo, K. E. D. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.08.011 · Cited by 20 · see citing works
Improving Cardiovascular Disease Prediction With Machine Learning Using Mental Health Data
Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., Wardill, H. R., van den Hengel, A., Narula, J., & Verjans, J. W. (2024) · JACC: Advances · doi:10.1016/j.jacadv.2024.101180 · Cited by 19 · see citing works
Similarities and dissimilarities between psychiatric cluster disorders
Smail, M. A., Wu, X., Henkel, N., Eby, H., Herman, J. P., McCullumsmith, R. E., & Shukla, R. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01030-3 · Cited by 17 · see citing works
Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients
Wei, H., Gu, J., Jiang, X., Deng, N., Wu, J., Zou, L., Zhu, Y., & Tan, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-92421-7 · Cited by 18 · see citing works
Kowalczys, A., Bohdan, M., Wilkowska, A., Pawłowska, I., Pawłowski, L., Janowiak, P., Jassem, E., Lelonek, M., Gruchała, M., & Sobański, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.895495 · Cited by 18 · see citing works
Liu, X., Lin, W., Huang, J., Cao, Z., Wu, M., Chen, Z., Zhu, W., Tan, Z., Yu, P., Ma, J., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.150 · Cited by 20 · see citing works
Depression and Coronary Artery Disease—Where We Stand?
Apostolos, A., Κωνσταντίνου, Κ., Ktenopoulos, N., Vlachakis, P. K., Skalidis, I., Chrysostomidis, G., Panoulas, V. F., & Tsioufis, K. P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124281 · Cited by 18 · see citing works
Castaldelli-Maia, J. M., Alves, C. H. F., Chagas, A. C. P., Liprandi, Á. S., Alcocer, A., Andrade, L. H., & Wielgosz, A. T. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06979-x · Cited by 17 · see citing works
Heart failure and depression: A perspective from bibliometric analysis
Lam, M. I., Chen, P., Xie, X., Lok, K.-I., Liu, Y.-F., Si, T. L., Ungvari, G. S., Ng, C. H., & Xiang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1086638 · Cited by 16 · see citing works
Chen, Y., Peng, W., Pang, M., Zhu, B., Liu, H., Hu, D., Luo, Y., Wang, S., Wu, S., He, J., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1306150 · Cited by 15 · see citing works
Depression Following Acute Coronary Syndrome: A Review
Pan, R., Fan, Q., & Tao, R. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409247 · Cited by 12 · see citing works
Cardiovascular disease and depression: a bidirectional relationship and its clinical implications
Wu, J., Tian, Z., Qi, Z., Liu, X., & Yu, P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1675680 · Cited by 13 · see citing works
Akimova, E. V., Kayumova, M. M., & Игоревна, Б. М. (2022) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202225071100 · Cited by 11 · see citing works
Adverse Cardiovascular Effects of Psychotropic Medications
Androshchuk, V., Montarello, N., & Rajani, R. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0773 · Cited by 11 · see citing works
Park, K., Kim, S., Ko, Y.-J., & Park, B. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113744 · Cited by 11 · see citing works
Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease
Chen, X., Xu, L., & Li, Z. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.852891 · Cited by 11 · see citing works
Adverse Events, Drug Interactions, and Treatment Adherence
Limandri, B. J. (2020) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20200117-02 · Cited by 11 · see citing works
Sandhu, U. G., Kovacs, A. H., & Nazer, B. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.09.011 · Cited by 11 · see citing works
A Mendelian randomization study of the effect of mental disorders on cardiovascular disease
Yu, Y., Yang, X., Wu, J., Hu, G., Bai, S., & Yu, R. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1329463 · Cited by 9 · see citing works
Ren, Y., Qi, D., Sun, N., Chang, Y., Mu, Y., Tian, X., Zhang, J., Wu, S., Luo, J., Yang, L., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.071 · Cited by 10 · see citing works
Yalçın, N., Özdemir, N., Esen, H. T. Ç., Kültür, S. E. Ç., & Demirkan, K. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14107 · Cited by 10 · see citing works
Bryant, K. B., Jannat‐Khah, D., Cornelius, T. M., Khodneva, Y. A., Richman, J., Fleck, E. M., Torres‐Deas, L. M., Safford, M. M., & Moise, N. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016661 · Cited by 10 · see citing works
Westas, M., Mourad, G., Andersson, G., Neher, M., Lundgren, J., & Johansson, P. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03939-7 · Cited by 10 · see citing works
Psychological Disorders in Heart Failure
Palo, K. E. D. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2021.12.014 · Cited by 9 · see citing works
Grippo, A. J., Scotti, M. L., Wardwell, J., McNeal, N., Bates, S. L., Chandler, D. L., Ihm, E., & Jadia, N. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.08.002 · Cited by 9 · see citing works
Identifying Stage D Heart Failure: Data From the Most Recent Registries
CASCINO, T. M., Aaronson, K. D., & Stewart, G. C. (2019) · Current Heart Failure Reports · doi:10.1007/s11897-019-00433-2 · Cited by 9 · see citing works
Burkina, V., Sakalli, S., Giang, P. T., Grabicová, K., Staňová, A. V., Zamaratskaia, G., & Žlábek, V. (2020) · Molecules · doi:10.3390/molecules25112690 · Cited by 8 · see citing works
Beyond the Heart: The Significance of Depression in Cardiac Surgery
Stenman, M., Jackson, V., Särnholm, J., Falk, A. S., Nielsen, S. J., & Sartipy, U. (2025) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaf277 · Cited by 8 · see citing works
Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies
Iervolino, A., Spadafora, L., Spadaccio, C., Iervolino, V., Biondi‐Zoccai, G., & Andreotti, F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010087 · Cited by 8 · see citing works
Quadackers, D. M. C., Liemburg, E. J., Bos, F. M., Doornbos, B., Risselada, A., PHAMOUS investigators, Bartels‐Velthuis, A. A., Bruggeman, R., Castelein, S., Jörg, F., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05022-1 · Cited by 8 · see citing works
Fi, B., Sumin, A. N., Garganeeva, N. P., Ларева, Н. В., Петрова, М. М., Петрунько, О. В., Попонина, Т. М., Repin, A. N., & Собенников, В. С. (2024) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2024-13-3s-222-253 · Cited by 7 · see citing works
Sandrini, L., Amadio, P., Ieraci, A., Malara, A., Werba, J. P., Soprano, P. M., Balduini, A., Zarà, M., Bonomi, A., Veglia, F., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112557 · Cited by 7 · see citing works
Ski, C. F., Taylor, R. S., McGuigan, K., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508 · Cited by 7 · see citing works
O’Connor, C. M. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.08.004 · Cited by 7 · see citing works
Alotaibi, R. N., Halbesma, N., Bijman, L., Clegg, G. R., Smıth, D. J., & Jackson, C. (2022) · Resuscitation Plus · doi:10.1016/j.resplu.2022.100214 · Cited by 6 · see citing works
Liu, W., Lin, Q. D., Fan, Z., Cui, J., & Wu, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304379 · Cited by 6 · see citing works
Improving Provider Adherence to Guideline Recommendations in Heart Failure
Palo, K. E. D., Piña, I. L., & Ventura, H. O. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0411-y · Cited by 6 · see citing works
Self-citationTang, M., & Li, X. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190160 · Cited by 6 · see citing works
Unmet challenges in treating hypertension in patients with borderline personality disorder
Roininen, S. M., Cheetham, M., Mueller, B. U., & Battegay, E. J. (2019) · Medicine · doi:10.1097/md.0000000000017101 · Cited by 6 · see citing works
Dalli, L. L., Andrew, N. E., Olaiya, M. T., Cadilhac, D. A.-M., Kim, J., Ung, D., Thrift, A. G., Phan, H., Gall, S., Nelson, M. R., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.050207 · Cited by 4 · see citing works
Ski, C. F., Taylor, R. S., McGuigan, K., Lambert, J. D., Richards, S. H., & Thompson, D. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013508.pub2 · Cited by 4 · see citing works
Валерьевна, О. М., Gorelik, S. G., Белоусова, О. Н., Avdeeva, I. V., & Крупенькина, Л. А. (2022) · PubMed Central · doi:10.22092/ari.2022.357395.2035 · Cited by 4 · see citing works
Multitargeting in cardioprotection: An example of biaromatic compounds
Мокров, Г. В. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300196 · Cited by 4 · see citing works
Tao, J., Dou, X., Chen, L., Hu, F., Li, Z., Gao, H., Li, X., Zhang, M., & Hu, Z. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2508277 · Cited by 4 · see citing works
Granata, L., Giubilato, S., Giuffrida, C., Pavan, D., Mojoli, M., Aspromonte, N., Fumarulo, I., Marchetta, M., Sbrigata, A., Pisano, C., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13070301 · Cited by 3 · see citing works
Awareness for Anxiety in Women: A Great Start
Smolderen, K. G. E., & Burg, M. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3116 · Cited by 3 · see citing works
Cheng, L., Zhong, Z., Ding, S., Duan, Y., Sun, N., & Zheng, F. (2023) · Journal of Health Psychology · doi:10.1177/13591053231173583 · Cited by 3 · see citing works
Lam, M. I., Bai, W., Feng, Y., Zhang, Q., Zhang, Y., Jackson, T., Rao, S.-Y., Ho, T.-I., Su, Z., Cheung, T. C. C., et al. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111910 · Cited by 3 · see citing works
Impact of Sudden Cardiac Arrest and Implantable Cardiac Defibrillator Shocks on Mental Health
Torbey, E., Mena‐Hurtado, C., Jackson, J. L., Samaan, Z., Sears, S. F., Pedersen, S. S., Lala, A., Thachil, R., Steiner, J. M., Ilonze, O. J., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101797 · Cited by 3 · see citing works
Fender, H., Kim, W., Kiper, A. K., Plačkić, J., Kisko, T. M., Braun, M. D., Schwarting, R. K. W., Rohrbach, S., Wöhr, M., Decher, N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129795 · Cited by 3 · see citing works
Levy, S., Cole, G., Pabari, P., Dani, M., Barton, C., Mayet, J., McDonagh, T. A., Baxter, J. K., & Plymen, C. M. (2021) · Age and Ageing · doi:10.1093/ageing/afab057 · Cited by 3 · see citing works
Efficiency and safety of Vortioxetine in the treatment of depressive disorders in cardiac patients
Filippova, N. V., Barylnik, Y. B., Богданова, Т. М., Blinova, V. V., Shchelchkova, A. A., & Mozgacheva, E. S. (2023) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2023-817 · Cited by 3 · see citing works
Chen, J., Lin, Z., Gong, Y., Jin-long, Y., Guo, F., Liu, Y., Liang, P. Q., Feng, Z., & Hao-ying, H. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111944 · Cited by 2 · see citing works
Shaker, A. H., Ibrahim, I. A., & Gharghan, S. K. (2024) · AIP conference proceedings · doi:10.1063/5.0236263 · Cited by 2 · see citing works
Wang, Y., & Li, S. (2025) · Brain and Behavior · doi:10.1002/brb3.70545 · Cited by 2 · see citing works
Versorgung von Herzinsuffizienzpatienten – eine interdisziplinäre Herausforderung
Störk, S., Angermann, C., Bauersachs, J. K., & Frantz, S. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1235-0422 · Cited by 2 · see citing works
Intervention options: depression and cardiovascular disease during COVID-19
Flouda, E., Stefanatou, A., & Apergi, T. (2023) · Global Cardiology · doi:10.4081/cardio.2023.5 · Cited by 2 · see citing works
Haghparast, P., Maroney, M. E., Salwan, A., & Sabbaugh, A. (2021) · Side effects of drugs annual · doi:10.1016/bs.seda.2021.08.010 · Cited by 2 · see citing works
Dasa, O., Mahmoud, A. N., Kaufmann, P. G., Ketterer, M., Light, K. C., Raczynski, J. M., Sheps, D. S., Stone, P. H., Handberg, E. M., & Pepine, C. J. (2022) · PubMed · doi:10.1097/psy.0000000000001044 · Cited by 1 · see citing works
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_2 · Cited by 1 · see citing works
Comparative Cardiovascular Safety of Duloxetine and Gabapentin in Patients with Hip Osteoarthritis
Moon, S., Choo, E., Choi, Y. J., & Shin, S. (2025) · Journal of Pain Research · doi:10.2147/jpr.s557621 · Cited by 1 · see citing works
Association of Baseline SSRI use with post-STEMI outcomes in patients with depression
Gopal, A., Kamrada, C., Awad, A., Chalhoub, M., Basit, J., & Alraies, M. C. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134585 · Cited by 1 · see citing works
Mind-Body Wellness Program Benefits
DePace, N. L., & Colombo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17016-5_9 · Cited by 2 · see citing works
Intervention options: depression and cardiovascular disease during COVID-19
Flouda, E., Stefanatou, A., & Apergi, T. (2023) · Global Cardiology · doi:10.4081/globalcard.2023.5 · Cited by 1 · see citing works
Connecting the Dots: Heart Failure and Insomnia
Kapica, M., Momot, K., Żmijewska, A., Sztybór, M., Krzyžanowska, M., Maleszewska, M., Piątkiewicz, J., Nowak, G., Wojtas, M., & Głogowska, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.62.013 · Cited by 1 · see citing works
Abbasi, S. H., Lund, L. C., Hallas, J., Ernst, M. T., & Pottegård, A. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.16406 · Cited by 1 · see citing works
Fi, B., Veltishchev, D. Y., Volel, B. A., Garganeeva, N. P., Kopylov, F. Y., Lareva, N. V., Medvedev, V. E., Mosolov, S. N., Petrova, M. M., Петрунько, О. В., et al. (2025) · Kardiologiia · doi:10.18087/cardio.2025.6.n2921 · Cited by 1 · see citing works
Psychotherapeutic treatments for depression in older adults
Ang, L., Lee, M. S., Song, E., Lee, H. W., Cao, L., Zhang, J., Wang, Q., Jung, J., Jang, S., Gastaldon, C., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015976
Editor-in-Chief’s Top Picks From 2018
Fuster, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.004
Cardiac Rehabilitation: Preliminary Results
Conti, C. R., CONTI, J. B., & Plasschaert, J. (2019) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2017.0069
Repurposing the atypical antidepressant trazodone for atherosclerotic cardiovascular diseasePreprint
Johnson, K. W., Narula, J., Glicksberg, B. S., Shameer, K., Chaudhry, F., Yahi, A., Khan, N. S., Amadori, L., Krittanawong, C., Readhead, B., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-567817/v1
New possibilities of screening for mental disorders in cardiology practice
Zadvorev, S. F., Dorofeikova, M., Петрова, Н. Н., & Yakovlev, A. (2021) · Vestnik of Saint Petersburg University Medicine · doi:10.21638/spbu11.2021.304
- Authors
- Piña, I. L., Di Palo, K. E., & Ventura, H. O.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Piña, Ileana L.
- ORCID
- Piña, Ileana L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 71
- Issue
- 20
- Pages
- 2346-2359
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2803606348
- Cited by
- 126
- References
- 131
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 20 · 2023: 20 · 2022: 23 · 2021: 13 · 2020: 11 · 2019: 11 · 2018: 5
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- psychopharmacology, cardiovascular disease, depression, anxiety, personality types, heart failure, cardiovascular mortality, psychotropic drugs, drug-drug interactions, elderly patients, cytochrome P450
- MeSH terms
- Mental Disorders, Cardiovascular Agents, Cardiovascular Diseases, Drug Interactions, Humans, Psychopharmacology, Psychotropic Drugs, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review